The praziquantel in preschoolers (PIP) trial: study protocol for a phase II PK/PD-driven randomised controlled trial of praziquantel in children under 4 years of age
DiscussionThe trial will provide valuable information on the safety and efficacy of the 80 mg/kg PZQ dose in PSAC, and on the impact of six-monthly versus annual treatment, in this vulnerable age group.Trial registrationClinicalTrials.govNCT03640377. Registered on 21 Aug 2018.
Source: Trials - Category: Research Source Type: clinical trials
More News: Child Development | Children | Endemics | Environmental Health | Nutrition | Philippines Health | Research | Study | Toxicology | Uganda Health